Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer.

International journal of clinical and experimental pathology - 1 Jan 2014

Jia Wei, Chang Bin, Sun Lili, Zhu Huimin, Pang Lijuan, Tao Lin, Zou Hong, Du Jinze, Dong Yuling, Qi Yan, Jiang Jinfang, Liang Weihua, Li Feng, Zhao Xia

Abstract excerpt

We investigated the clinical significance of regulated in development and DNA damage response (REDD1) and p-AKT expression in human ovarian cancer (OC), explored the correlation of KRAS mutations with REDD1 expression, and assessed the therapeutic relevance of REDD1 in OC. We collected and immunohistochemically analyzed 118 formalin-fixed paraffin-embedded tumor tissue samples (100 primary OC and 18 borderline...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Grading

Share to Ovarian Neoplasms

Share to Proto-Oncogene Proteins c-akt

Share to ras Proteins

Share to Real-Time Polymerase Chain Reaction

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 25337238
PMCID: PMC4203209

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer.PMID 25337238Read ↗

NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2Semantic proximity Read ↗

The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesisSemantic proximity Read ↗

Identification of Receptor Tyrosine Kinase, Discoidin Domain Receptor 1 (DDR1), as a Potential Biomarker for Serous Ovarian CancerSemantic proximity Read ↗

BAD-mediated apoptotic pathway is associated with human cancer developmentSemantic proximity Read ↗

AKT1 interacts with DHX9 to Mitigate R Loop–Induced Replication Stress in Ovarian CancerSemantic proximity Read ↗

LncRNA RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer via upregulation of RAD51BSemantic proximity Read ↗

ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferationSemantic proximity Read ↗

Alteration of REDD1-mediated mammalian target of rapamycin pathway and hypoxia-inducible factor-1α regulation in human breast cancer.Semantic proximity Read ↗

Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinomaSemantic proximity Read ↗

BRDT promotes ovarian cancer cell growthSemantic proximity Read ↗

Inhibitor of DNA-binding family regulates the prognosis of ovarian cancer.Semantic proximity Read ↗

Inhibition of LncRNA THUMPD3-AS1 enhances olaparib-induced autophagy in BRCA mutant ovarian cancer cells via PI3K pathway.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.